- By Ben Schiller
- 1 minute Read
Company | Profile
The company's competitive advantage in 2016:
A track record of success with the FDA and patients for its immuno-oncology drugs
The biggest challenges standing in this company's way in 2016:
The company may see increasing competition in immuno-oncologynumerous companies large and small have drugs in some stage of clinical trials.
The political mood could present another challengelike most drugmakers, BSM gets the bulk of its profits from very high-priced drugs, which are increasingly under scrutiny by lawmakers.
What to look out for:
The results of trials for Opdivo--alone and in combination treatments--in additional types of cancer
Top perks for employees:
Leadership training programs, tuition assistance, college scholarship awards for children of employees (up to 50 scholarships annually), domestic partner benefits, on-site childcare and childcare discounts, flexible working arrangements, cash recognition awards (separate from regular bonuses).
Prescription drug coverage includes most Bristol-Myers Squibb-branded prescriptions free of charge. In 2015, BMS was recognized by a Science Careers survey as a top 20 R&D employer, one of Glassdoor's top 50 best places to work, and a top 100 workplace by Working Mother.
Social media handles:
31.5% women at the executive level
28.7% minorities across the company, including 14.4% at the executive level
BMS received a perfect score on the 2015 Corporate Equality Index, a national review of workplace equality conducted annually by the Human Rights Campaign Foundation, the nation's largest LGBT civil rights organization.